Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lawrence W. Williams"'
Autor:
Pamela G. Coxson, Lawrence W. Williams, Lee Goldman, James Lightwood, Kirsten Bibbins-Domingo
Publikováno v:
American Journal of Preventive Medicine. 36:13-20
Background Passive smoking is a major risk factor for coronary heart disease (CHD), and existing estimates are out of date due to recent and substantial changes in the level of exposure. Objective To estimate the annual clinical burden and cost of CH
Autor:
Jean-Michel Gaspoz, Lawrence W. Williams, Karen M. Kuntz, Pamela G. Coxson, Lee Goldman, M. G. Myriam Hunink, Paula A. Goldman
Publikováno v:
New England Journal of Medicine, 346, 1800-1806. Massachussetts Medical Society
Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary heart disease. We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both for secondary prevention in patients with coronar
Publikováno v:
American Journal of Public Health. 80:1481-1486
Using a simulation model of the US male population, we estimated the long-term impact that future smoking cessation programs would have on the distribution and occurrence of coronary heart disease in males ages 35-84. For interventions that reduce th
Autor:
Elizabeth M. Ross, Milton C. Weinstein, Pamela G. Coxson, Paula A. Goldman, Irwin H. Rosenberg, Jeffrey A. Tice, Lee Goldman, M. G. Myriam Hunink, Lawrence W. Williams
Publikováno v:
JAMA-Journal of the American Medical Association, 286, 936-943. American Medical Association
ContextA high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 1998, the US Food and Drug Administration has required that all enriched grain products con
Autor:
Kathryn A. Phillips, Paula A. Goldman, Milton C. Weinstein, M. G. Myriam Hunink, Pamela G. Coxson, Lawrence W. Williams, Lee Goldman
Publikováno v:
Journal of the American College of Cardiology, 38, 1012-1017. Elsevier Inc.
OBJECTIVES We sought to estimate the impact and cost-effectiveness of risk factor reductions between 1981 and 1990. BACKGROUND Coronary heart disease (CHD) mortality rates have declined dramatically, partly as a result of reductions in CHD risk facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bdfa3bff2fe8d88d99511a89163a46
https://pure.eur.nl/en/publications/dedf46b9-2628-4a0f-acdd-c6c73cb5fd4a
https://pure.eur.nl/en/publications/dedf46b9-2628-4a0f-acdd-c6c73cb5fd4a
Autor:
Kathryn A. Phillips, Paul A. Heidenreich, M. G. Myriam Hunink, Milton C. Weinstein, Lawrence W. Williams, Paula A. Goldman, Lee Goldman, Michael G. Shlipak, Pamela G. Coxson
Publikováno v:
JAMA. 284(21)
Contextβ-Blockers are underused in patients who have myocardial infarction (MI), despite the proven efficacy of these agents. New evidence indicates that β-blockers can have benefit in patients with conditions that have been considered relative con
Autor:
M. G. Myriam Hunink, Lisa A. Prosser, Aaron A. Stinnett, Paula A. Goldman, Milton C. Weinstein, Lee Goldman, Lawrence W. Williams
Publikováno v:
Annals of Internal Medicine, 132(10), 769-779. American College of Physicians
The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) recommends treatment guidelines based on cholesterol level and number of risk factors.To ev
Autor:
Sally S. Araki, Milton C. Weinstein, Paula A. Goldman, Richard C. Hermann, S. B. Duff, Karen M. Kuntz, P. A. Berenbaum, Joel Leon, Lawrence W. Williams, Peter J. Neumann
Publikováno v:
Neurology. 52(6)
Objective: To demonstrate the use of cost-effectiveness analysis to assess the economic impact of donepezil in the treatment of mild or moderate AD. Background: Cost-effectiveness analyses show the relationship between resources used (costs) and heal
Autor:
Anna N. A. Tosteson, Lee Goldman, M. G. Myriam Hunink, Paula A. Goldman, Lawrence W. Williams, Milton C. Weinstein, Murray A. Mittleman
Publikováno v:
Circulation, 95(1), 24-30. LIPPINCOTT WILLIAMS & WILKINS
Background The aim of the present study was to estimate the cost-effectiveness of populationwide approaches to reduce serum cholesterol levels in the US adult population. Methods and Results This cost-effectiveness analysis was made from data from th
Publikováno v:
The American journal of cardiology. 72(10)
When used for the primary prevention of coronary heart disease in persons with heterozygous familial hypercholesterolemia (hFH), a hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitor is projected to be effective and to have very favorable